Case Studies and White Papers

  • Patient Advisory Board, Chronic Respiratory Disease

    Gathering patient perspectives on educational materials is critical. In order to efficiently collect actionable feedback from a group of patients, a patient advocacy team within a leading pharmaceutical company held a two-week virtual advisory board. Patients viewed resources within the platform, which they could access 24/7 from any connected device. Read the case study to learn how patient input helped improve the educational materials.

  • Internal Training Advisory Board

    A medical affairs team used the Within3 virtual engagement platform to get feedback on proposed training activities. As a result, the team saved weeks of time normally spent obtaining internal alignment and established a repeatable process for future training initiatives.

  • Medical Affairs Three-Part Session, Oncology

    A medical affairs team needed to engage a group of oncology and hematology specialists to gather insight on various topics around a rare type of cancer. In a pre-session webcast, the team maximized advisors' time by setting expectations prior to a two-week asynchronous advisory board, and then conducted a post-session webcast to review areas of consensus and collect final thoughts.

  • Medical Aesthetics Virtual Advisory Board, APAC

    A medical affairs team needed insights on the use of a procedure among aestheticians in Mainland China and Taiwan. Within3 worked with the team to design a 10-day session with different question types to obtain quantitative and qualitative feedback. At the conclusion of the over-time session, the aestheticians participated in a live webcast to discuss the results of the advisory board.

  • US Commercial Advisory Board, Infectious Disease

    A US-based commercial team within a global pharmaceutical company wanted to gather insight from physicians who specialize in treating a specific infectious disease. Within3 guided the team through a pre-session webcast to solidify objectives, followed by a week-long advisory board session to review resources and provide feedback.

  • Resource Center for Congress Highlights

    A medical affairs team within a leading global life sciences company needed to establish a way to internally share posters, abstracts, and symposium recordings from medical congress events. Learn how Within3 helped the team set up a resource center to share information in a single, authoritative location.

  • US Medical Device Advisory Board

    A medical affairs team wanted to obtain feedback from physicians experienced in treating a type of neurological injury and a condition related to the injury. The team wanted to present details about a new therapy option – a portable medical device – to treat the related condition, then gather the physicians' thoughts on the new therapy.

  • Best Practices in Over-Time Virtual Patient Engagement

    The pharmaceutical industry is energizing its approach to patient engagement, adopting a patient-centric philosophy that prioritizes involving patients in a meaningful way throughout the drug development lifecycle. Both patients and pharmaceutical teams can benefit from over-time, asynchronous communication. We've compiled some of our best practices around these types of meetings to help medical affairs, clinical/R&D, and commercial teams get high-quality insights in a virtual engagement setting.

  • European Physician Advisory Board – Medical Affairs, Oncology

    A European medical affairs team wanted to obtain opinions and feedback on key study data presented at a medical congress. The team had already planned a face-to-face meeting with one group of oncologists, but wanted to solicit feedback from a different group of oncologists who normally would not have been included in the face-to-face meeting. The team used Within3 to conduct a virtual meeting with the second group and obtained robust insights within a short period of time.

  • The Live-to-Virtual Pivot: 4 Best Practices

    The events of early 2020 changed how life sciences companies do business almost overnight, forcing teams to convert live events to virtual meetings. But standing up a reliable way to meet with stakeholders online isn't just a stopgap – it's an investment for the future. Learn four best practices that will enable your team to make a successful switch to virtual meetings.

  • Eastern Europe Sleep Disorders Advisory Board

    A medical affairs team based in Eastern Europe wanted to engage a group of physicians to better understand the ramifications of certain sleep disorders. Because it was impractical to conduct a live meeting due to a limited budget and the physicians' busy schedules, the team elected to hold a virtual, over-time meeting on the Within3 platform.

  • Streamlining Regional Communications in APAC

    In some regions of the world, long distances and multiple languages make live, in-person meetings particularly costly and inefficient. With APAC spending on business travel expected to reach $900 billion by 2025, global pharmaceutical companies are increasingly turning to virtual engagement to reduce spending and environmental impact.

  • Global Patient Advisory Board – Rare Disease

    A medical affairs team within a leading pharmaceutical company wanted to gather patient perspectives about living with a chronic, but treatable, rare disease. The team used the Within3 virtual engagement platform to reach out to patients in the United States, Canada, and Europe – not all of whom would be able to travel or attend a webcast at the same time.

  • Rare Disease Task Force – Africa

    FYMCA Medical Ltd, a UK-based company that develops improved rare disease education and services for the developing world, wanted to identify problems impacting the care patients with rare diseases receive in resource-limited countries across Africa. The company formed a task force of rare disease clinicians and patient groups and used Within3 to hold a virtual session for the group to work toward its goals.

  • Physician Virtual Advisory Board – Latin America

    A medical affairs team in Latin America wanted expert feedback on several key issues related to a specific drug used to treat a chronic condition. Because the physician experts were located in several different Latin American countries and had little time to travel, the team opted to conduct an advisory board meeting by using an online engagement platform.

  • Engaging Global Payers for Better Trial Design

    A clinical team wanted to design a Phase III trial for a new therapy used to treat a rare disease. To gauge the economic viability of the new treatment, the team needed to understand how global payer organizations would weigh the benefits of the new therapy, and where the treatment might be placed in formularies. The team used Within3 to conduct a three-week, multi-part online advisory board meeting to efficiently gather input from payers around the world.

  • Oncology Virtual Advisory Board - Europe

    A medical affairs team within a leading pharmaceutical company wanted to identify unmet needs in the treatment of a specific type of cancer in the European patient population. They used a virtual engagement platform to eliminate scheduling conflicts and language barriers and achieve their objectives.

  • Leveraging an Expert Panel for Message Testing

    A pharmaceutical company wanted timely feedback on physician-targeted messaging around a new drug delivery method. The company maintains a standing panel of experts accessible via the Within3 virtual engagement platform and was able to quickly call on a group of HCPs to provide input on the proposed messaging. The drug company also obtained critical information about treatment patterns and what types of patients might be considered for the new drug delivery mechanism.

  • Transforming Communication on an Enterprise Scale

    Online discussion platforms improve business insights, enable more frequent customer touchpoints, and lower costs compared to traditional communication methods. Life sciences companies around the world are adding this capability across their enterprises to reduce costs, save time, and improve the overall quality of communication.

  • Streamlining Publications Development with Real-Time Co-Authoring

    A multibillion-dollar global pharmaceutical firm became frustrated with the time-consuming and labor-intensive publication process and wanted to improve it. To achieve its primary goals of finalizing a manuscript more quickly and improving the overall experience for authors, the company decided to use a co-authoring platform to shorten timelines, keep proprietary information secure, and give authors more flexibility to make more thoughtful and thorough contributions.